New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Creso Pharma Limited
CPH.AX
Shape
US Flag

ASX

Unprofitable

Unprofitable

23M

Drug Manufacturers - Specialty & Generic

0.01AUD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-91%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

83%

Quote Panel

Shape
Updated October 28, 2024
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    23.11M


  • Shares Outstanding

    2.57B


  • Share in Float

    1.51B


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.009


  • Average Volume

    10.01M


  • Beta

    2.624371


  • Range

    0.008-0.053


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cresopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.66x

P/S Ratio

0.59x

P/B Ratio

0.3

Debt/Equity

-377.3%

Net Margin

$-0.0

EPS

How CPH.AX compares to sector?

P/E Ratio

Relative Strength

Shape

CPH.AX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.17

arrow
arrow

N/A

NA
vs -0.04

Q2.17

arrow
arrow

+100%

NA
vs -0.04

Q4.17

arrow
arrow

N/A

NA
vs NA

Q1.18

arrow
arrow

N/A

-0.04
vs NA

Q2.18

arrow
arrow

N/A

-0.04
vs NA

Q4.18

arrow
arrow

N/A

NA
vs NA

Q1.19

arrow
arrow

N/A

-0.03
vs -0.04

Q2.19

arrow
arrow

N/A

-0.03
vs -0.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.17

arrow
arrow

+2939%

60.9K  vs 2K

Q2.17

arrow
arrow

+2939%

60.9K  vs 2K

Q4.17

arrow
arrow

NA

139.6K  vs NA

Q1.18

arrow
arrow

+129%

139.6K  vs 60.9K

Q2.18

arrow
arrow

+129%

139.6K  vs 60.9K

Q4.18

arrow
arrow

+549%

906.6K  vs 139.6K

Q1.19

arrow
arrow

+549%

906.6K  vs 139.6K

Q2.19

arrow
arrow

+549%

906.6K  vs 139.6K

Return on EquityShape

status-upQoQ

Q2.18

arrow
arrow

NA

NA
vs NA

Q4.18

arrow
arrow

-26%

-0.26
vs NA

Q1.19

arrow
arrow

NA

NA
vs -0.26

Q2.19

arrow
arrow

NA

NA
vs NA

Q4.19

arrow
arrow

NA

NA
vs NA

Q4.20

arrow
arrow

NA

NA
vs NA

Q4.21

arrow
arrow

NA

NA
vs NA

Q4.22

arrow
arrow

NA

NA
vs NA

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News